p53 signaling pathway polymorphisms, cancer risk and tumor phenotype in TP53 R337H mutation carriers
In conclusion, our results suggest that MDM2 SNP 309 may contribute to the LFL phenotype and also to an earlier age at diagnosis of ACC and BC cancer in carriers of the R337H founder mutation.
Source: Familial Cancer - Category: Cancer & Oncology Source Type: research
More News: Adrenocortical Carcinoma | Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Genetics | Statistics | Study